Helix 3-helix 5 interactions in steroid hormone receptor function

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 3-5, 2008, Pages 279-285

  Zhang, Junhui ^a   Geller, David S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CRYSTAL STRUCTURE; GENE FUNCTION; GENE MUTATION; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; NONHUMAN; PROTEIN PROTEIN INTERACTION;

HUMANS; LIGANDS; MUTATION; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STEROIDS;

EID: 43849091409     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.03.018     Document Type: Article

References (34)

1. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., and Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 6652 (1997) 753-758
2. Williams S.P., and Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature 393 6683 (1998) 392-396
3. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., Lambert M.H., Moore J.T., Pearce K.H., and Xu H.E. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110 1 (2002) 93-105
4. Kauppi B., Jakob C., Farnegardh M., Yang J., Ahola H., Alarcon M., Calles K., Engstrom O., Harlan J., Muchmore S., Ramqvist A.K., Thorell S., Ohman L., Greer J., Gustafsson J.A., Carlstedt-Duke J., and Carlquist M. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J. Biol. Chem. 278 25 (2003) 22748-22754
5. Fagart J., Huyet J., Pinon G.M., Rochel M., Mayer C., and Rafestin-Oblin M.E. Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat. Struct. Mol. Biol. 12 6 (2005) 554-555
6. Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S., Otto N., Joschko S., Scholz P., Wegg A., Basler S., Schafer M., Egner U., and Carrondo M.A. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J. Biol. Chem. 275 34 (2000) 26164-26171
7. Bledsoe R.K., Madauss K.P., Holt J.A., Apolito C.J., Lambert M.H., Pearce K.H., Stanley T.B., Stewart E.L., Trump R.P., Willson T.M., and Williams S.P. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J. Biol. Chem. 280 35 (2005) 31283-31293
8. Li Y., Suino K., Daugherty J., and Xu H.E. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol. Cell 19 3 (2005) 367-380
9. Moras D., and Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10 3 (1998) 384-391
10. Beato M., Herrlich P., and Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 6 (1995) 851-857
11. Fagart J., Wurtz J.M., Souque A., Hellal-Levy C., Moras D., and Rafestin-Oblin M.E. Antagonism in the human mineralocorticoid receptor. EMBO J. 17 12 (1998) 3317-3325
12. Vivat V., Gofflo D., Garcia T., Wurtz J.M., Bourguet W., Philibert D., and Gronemeyer H. Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities. J. Mol. Endocrinol. 18 2 (1997) 147-160
13. Poujol N., Wurtz J.M., Tahiri B., Lumbroso S., Nicolas J.C., Moras D., and Sultan C. Specific recognition of androgens by their nuclear receptor. A structure-function study. J. Biol. Chem. 275 31 (2000) 24022-24031
14. Dey R., Roychowdhury P., and Mukherjee C. Homology modelling of the ligand-binding domain of glucocorticoid receptor: binding site interactions with cortisol and corticosterone. Protein Eng. 14 8 (2001) 565-571
15. Lind U., Greenidge P., Gillner M., Koehler K.F., Wright A., and Carlstedt-Duke J. Functional probing of the human glucocorticoid receptor steroid-interacting surface by site-directed mutagenesis. Gln-642 plays an important role in steroid recognition and binding. J. Biol. Chem. 275 25 (2000) 19041-19049
16. Marhefka C.A., Moore II B.M., Bishop T.C., Kirkovsky L., Mukherjee A., Dalton J.T., and Miller D.D. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands. J. Med. Chem. 44 11 (2001) 1729-1740
17. Lind U., Greenidge P., Gustafsson J.A., Wright A.P., and Carlstedt-Duke J. Valine 571 functions as a regional organizer in programming the glucocorticoid receptor for differential binding of glucocorticoids and mineralocorticoids. J. Biol. Chem. 274 26 (1999) 18515-18523
18. Steinmetz A.C., Renaud J.P., and Moras D. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 30 (2001) 329-359
19. Geller D.S., Farhi A., Pinkerton N., Fradley M., Moritz M., Spitzer A., Meinke G., Tsai F.T., Sigler P.B., and Lifton R.P. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289 5476 (2000) 119-123 (see comment)
20. Benhamou B., Garcia T., Lerouge T., Vergezac A., Gofflo D., Bigogne C., Chambon P., and Gronemeyer H. A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 255 5041 (1992) 206-209
21. Egea P.F., Mitschler A., Rochel N., Ruff M., Chambon P., and Moras D. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 19 11 (2000) 2592-2601
22. Gampe Jr. R.T., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., and Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5 3 (2000) 545-555
23. Zhang J., Simisky J., Tsai F.T., and Geller D.S. A critical role of helix 3-helix 5 interaction in steroid hormone receptor function. Proc. Natl. Acad. Sci. U.S.A. 102 8 (2005) 2707-2712
24. Weis K.E., Ekena K., Thomas J.A., Lazennec G., and Katzenellenbogen B.S. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10 11 (1996) 1388-1398
25. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., and Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5 2 (2000) 289-298
26. Chen S., Zhou D., Yang C., and Sherman M. Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. J. Biol. Chem. 276 30 (2001) 28465-28470
27. Chakraborti P.K., Garabedian M.J., Yamamoto K.R., and Simons Jr. S.S. Creation of "super" glucocorticoid receptors by point mutations in the steroid binding domain. J. Biol. Chem. 266 33 (1991) 22075-22078
28. Yu C., Warriar N., and Govindan M.V. Cysteines 638 and 665 in the hormone binding domain of human glucocorticoid receptor define the specificity to glucocorticoids. Biochemistry 34 43 (1995) 14163-14173
29. Warriar N., Yu C., and Govindan M.V. Hormone binding domain of human glucocorticoid receptor. Enhancement of transactivation function by substitution mutants M565R and A573Q. J. Biol. Chem. 269 46 (1994) 29010-29015
30. Terouanne B., Nirde P., Rabenoelina F., Bourguet W., Sultan C., and Auzou G. Mutation of the androgen receptor at amino acid 708 (Gly → Ala) abolishes partial agonist activity of steroidal antiandrogens. Mol. Pharmacol. 63 4 (2003) 791-798
31. Auzou G., Fagart J., Souque A., Hellal-Levy C., Wurtz J.M., Moras D., and Rafestin-Oblin M.E. A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones. Mol. Pharmacol. 58 4 (2000) 684-691
32. Lim-Tio S.S., Keightley M.C., Fletcher T.P., and Fuller P.J. The molecular basis of RU486 resistance in the Tammar Wallaby, Macropus eugenii. Mol. Cell. Endocrinol. 119 2 (1996) 169-174
33. Zhang J., Tsai F.T., and Geller D.S. Differential interaction of RU486 with the progesterone and glucocorticoid receptors. J. Mol. Endocrinol. 37 1 (2006) 163-173
34. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22 22 (1994) 4673-4680